Form 4: SpringWorks Therapeutics Executive Sells Shares to Cover Tax Obligations

A SpringWorks Therapeutics executive, Daniel Pichl, sold shares to cover tax obligations related to vesting restricted stock units.

Summary

• Daniel Pichl, Chief People Officer at SpringWorks Therapeutics, sold shares of common stock to cover tax obligations.
• The transactions occurred on January 4th, 5th and 6th of 2025.
• A total of 7,269 shares were sold at prices of $38.19 and $38.86.
• The sales were not discretionary but were to cover tax liabilities associated with the vesting of restricted stock units.
• Following these transactions, Mr. Pichl beneficially owns 37,943 shares of SpringWorks Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment towards the company's prospects.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when restricted stock units vest.

Comparison to Industry Standards

• Similar transactions are common across the pharmaceutical and biotech industries where stock-based compensation is a significant part of executive pay.
• Companies like Amgen, Gilead, and Biogen also see similar filings from their executives regularly.
• These transactions are generally not indicative of a change in the executive's outlook on the company's future, but rather a standard part of compensation management.

Stakeholder Impact

• The share sales have a minimal impact on shareholders as they are routine transactions for tax purposes.
• The transactions do not indicate any change in the company's operations or outlook.

Key Dates

Keywords

SpringWorks Therapeutics, insider trading, stock sale, tax obligations, restricted stock units, SWTX, Daniel Pichl, Chief People Officer